SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-019005
Filing Date
2013-04-01
Accepted
2013-04-01 14:25:34
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v337317_10k.htm 10-K 1211864
2 EXHIBIT 31.1 v337317_ex31-1.htm EX-31.1 7345
3 EXHIBIT 31.2 v337317_ex31-2.htm EX-31.2 7307
4 EXHIBIT 32.1 v337317_ex32-1.htm EX-32.1 3926
5 EXHIBIT 32.2 v337317_ex32-2.htm EX-32.2 3972
  Complete submission text file 0001144204-13-019005.txt   6995520

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arni-20121231.xml EX-101.INS 759840
7 XBRL TAXONOMY EXTENSION SCHEMA arni-20121231.xsd EX-101.SCH 86641
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20121231_cal.xml EX-101.CAL 51035
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20121231_def.xml EX-101.DEF 373450
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20121231_lab.xml EX-101.LAB 679076
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20121231_pre.xml EX-101.PRE 439831
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

IRS No.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52153 | Film No.: 13730437
SIC: 2834 Pharmaceutical Preparations